These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27030838)

  • 1. [Tanakan as a multimodal cytoprotective factor in general medicine].
    Naprienko MV; Esin RG; Mukhametova ER; Esin OR; Smekalkina LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):146-151. PubMed ID: 27030838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tanakan as a multimodal cytoprotective factor in general medicine (part II)].
    Esin RG; Naprienko MV; Mukhametova ER; Khairullin IK; Esin OR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):177-182. PubMed ID: 26978514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment.
    Băjenaru O; Prada G; Antochi F; Jianu C; Tudose C; Cuciureanu A; Docu AA; Perrot V; Avram M; Tiu C
    CNS Neurol Disord Drug Targets; 2021; 20(4):378-384. PubMed ID: 33557741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience in clinical use of tanakan in the treatment of the syndrome of mild cognitive impairment].
    Gavrilova SI; Fedorova IaB; Roshchina IF; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(10):42-6. PubMed ID: 17117673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.
    McKenna DJ; Jones K; Hughes K
    Altern Ther Health Med; 2001; 7(5):70-86, 88-90. PubMed ID: 11565403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGB761 ameliorates chronic cerebral hypoperfusion-induced cognitive dysfunction and synaptic plasticity impairment.
    Yao ZH; Wang J; Yuan JP; Xiao K; Zhang SF; Xie YC; Mei JH
    Aging (Albany NY); 2021 Feb; 13(7):9522-9541. PubMed ID: 33539323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of asthenic disorders with tanakan].
    Milopol'skaia IM
    Ter Arkh; 2001; 73(10):45-7. PubMed ID: 11763515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tanakan (EGb 761) in the therapy of mild cognitive impairment].
    Iakhno NN; Zakharov VV; Lokshina AB; Gavrilova SI; Fedorova IaB; Gustov AV; Korshunova IuA; Dziak LA; Miziakina EV; Odinak MM; Emelin AIu; PilipenkoP I ; Vostrikova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(12):41-6. PubMed ID: 17274394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of tanakan in disturbances of memory and attention in the elderly].
    Zakharov VV
    Ter Arkh; 2002; 74(12):95-100. PubMed ID: 12577855
    [No Abstract]   [Full Text] [Related]  

  • 10. Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.
    Shi C; Liu J; Wu F; Yew DT
    Int J Mol Sci; 2010 Jan; 11(1):107-23. PubMed ID: 20162004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761.
    Luo Y; Smith JV; Paramasivam V; Burdick A; Curry KJ; Buford JP; Khan I; Netzer WJ; Xu H; Butko P
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12197-202. PubMed ID: 12213959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.
    Amieva H; Meillon C; Helmer C; Barberger-Gateau P; Dartigues JF
    PLoS One; 2013; 8(1):e52755. PubMed ID: 23326356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of Ginkgo biloba extract.
    Ahlemeyer B; Krieglstein J
    Cell Mol Life Sci; 2003 Sep; 60(9):1779-92. PubMed ID: 14523543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba leaf extract (EGb761) combined with neuroprotective agents reduces the infarct volumes of gerbil ischemic brain.
    Chung SY; Cheng FC; Lee MS; Lin JY; Lin MC; Wang MF
    Am J Chin Med; 2006; 34(5):803-17. PubMed ID: 17080546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral insulin resistance: current concepts of the pathogenesis and possible therapeutic strategies].
    Esin RG; Khairullin IK; Esin OR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):92-95. PubMed ID: 29460912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses.
    Mahadevan S; Park Y
    J Food Sci; 2008 Jan; 73(1):R14-9. PubMed ID: 18211362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evidence of the neuroprotective effect of Ginkgo biloba (EGb761) using bax/bcl-2 ratio after brain ischemia in senescence-accelerated mice, strain prone-8.
    Lu G; Wu Y; Mak YT; Wai SM; Feng ZT; Rudd JA; Yew DT
    Brain Res; 2006 May; 1090(1):23-8. PubMed ID: 16677616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of hyperbaric oxygen and Ginkgo biloba extract on Aβ25-35-induced oxidative stress and neuronal apoptosis in rats.
    Tian X; Zhang L; Wang J; Dai J; Shen S; Yang L; Huang P
    Behav Brain Res; 2013 Apr; 242():1-8. PubMed ID: 23266522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo and Alzheimer's disease: little or no different from placebo.
    Prescrire Int; 2007 Oct; 16(91):205-7. PubMed ID: 17926840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.